NCT03469284View on ClinicalTrials.gov

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

February 3, 2022

Study Completion Date

February 3, 2022

Conditions
Malignant NeoplasmOral PainStomatitis
Interventions
OTHER

Best Practice

Given standard of care therapy

DRUG

Methylene Blue

Given lower dose PO

DRUG

Methylene Blue

Given medium dose PO

DRUG

Methylene Blue

Given higher dose PO

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT03469284 - MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN) | Biotech Hunter | Biotech Hunter